Showing 51-60 of 290 results for "".
DermWireTV 09.12.19: Otezla to Amgen, A Juvéderm First, Skin Cancer Foundation News
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-091219-otezla-to-amgen-a-juvederm-first-skin-cancer-foundation-news/19663/After traveling more than 10,000 miles across the US, the Skin Cancer Foundation’s “Destination: Healthy Skin” Program is wrapping up for the season. Plus, the Champions for Change Gala is coming October 17. Amgen has entered into an agreement with Celgene Corporation Company to acquire worldwide riHarnessing the Power of Humor for Psoriasis
https://practicaldermatology.com/topics/psoriasis/harnessing-the-power-of-humor-for-psoriasis/23007/Humor can create positive changes in our thoughts, feelings, behaviors, and biochemistry and can also influence how patients cope.Re-introducing Ortho Dermatologics, Tremfya Approved, Obagi Acquired
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-re-introducing-ortho-dermatologics-tremfya-approved-obagi-acquired/18458/Valeant Pharmaceuticals is changing the name of its dermatology division to Ortho Dermatologics. In an exclusive interview with DermWireTV, Executive Vice President and dermatology industry veteran William Bill Humphries discusses the change. The FDA has approved Janssen Biotech's Tremfya (guselkumaKeys for Practice Success in 2017
https://practicaldermatology.com/topics/practice-management/keys-for-practice-success-in-2017/20838/The way patients choose physicians is changing, so physicians need to change the way they grow their practices.The Future of Atopic Dermatitis Therapy
https://practicaldermatology.com/topics/general-topics/the-future-of-atopic-dermatitis-therapy/21143/As new research elucidates the individual mechanisms of atopic dermatitis, the development of therapies that more directly influence the disease may change the scope of treatment.HIPAA Update
https://practicaldermatology.com/topics/practice-management/hipaa-update/19115/Michael J. Sacopulos, JD, Founder and President of Medical Risk Institute talks about recent changes to HIPAA and their possible implications for aesthetic medicine and cosmetic surgery practices. From Vegas Cosmetic Surgery.Business Advisor: Mapping Out a Price/Benefit Value Strategy for Your Practice
https://practicaldermatology.com/topics/general-topics/business-advisor-mapping-out-a-pricebenefit-value-strategy-for-your-practice/22043/Using a Price/Benefit map is a good way for practices to set prices and plan to adapt to changing markets.DERM2021: An Opportunity to Learn
https://practicaldermatology.com/series/dermatology-education-foundation/derm2021-an-opportunity-to-learn/19992/Suneel Chilukuri, MD shares what he got out of the DERM2021 NP/PA CME Conference—a chance to interact with attendees and presenters and learn from one another.Scientifically Speaking: New Directions in Acne Management, Part 1
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-new-directions-in-acne-management-part-1/19939/The recognition that inflammation is at the heart of acne has led to changes in management approaches and better understanding of how treatments work. In the first of a 2-part series, host Joel L. Cohen, MD talks to Diane Berson, MD; Linda Stein Gold, MD; and Emil Tanghetti, MD about acne approachesSocial Media Can be Your Aesthetic Magic
https://practicaldermatology.com/topics/practice-management/social-media-can-be-your-aesthetic-magic/23094/Social media is changing the aesthetic market by enabling two-way communication between the practice and its followers.